awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q54210704-301DCB91-E7D2-4C41-9ED6-B96170EFDEED
Q54210704-301DCB91-E7D2-4C41-9ED6-B96170EFDEED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54210704-301DCB91-E7D2-4C41-9ED6-B96170EFDEED
Grazoprevir/elbasvir for the treatment of adults with chronic hepatitis C: a short review on the clinical evidence and place in therapy.
P2860
Q54210704-301DCB91-E7D2-4C41-9ED6-B96170EFDEED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54210704-301DCB91-E7D2-4C41-9ED6-B96170EFDEED
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3f9b25daaf6f1f32b4995de45bfe28a22665e636
P2860
Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a